Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the active ingredient in both Wegovy® and Ozempic®. It plays a vital role in both diabetes and weight management because it helps control hunger and regulate blood sugar.
It is available to patients with a body mass index (BMI) of over 30 kg/m² or individuals with a BMI of over 27 kg/m² alongside at least one weight-related condition, such as type 2 diabetes, prediabetes, high cholesterol, or sleep apnea.
Combined with a healthy, low-calorie diet and exercise routine, semaglutide has shown promising results. Many patients report enhanced blood sugar control and noticeable weight loss with semaglutide. It's important to note that individual responses may vary. Lifestyle changes, including a healthy fitness plan and diet, are the cornerstones of health and wellness. Medications for weight management used without these cornerstones will only provide a temporary change and not be effective long term.